RJx-01
COPD-related Muscle Weakness and Sarcopenia
Phase 2Active
Key Facts
Indication
COPD-related Muscle Weakness and Sarcopenia
Phase
Phase 2
Status
Active
Company
About Rejuvenate Biomed
Rejuvenate Biomed is an AI-enabled, clinical-stage biotech based in Leuven, Belgium, focused on developing prescription drugs for healthy aging. The company is advancing a pipeline led by RJx-01, currently in a Phase 2 trial for COPD-related sarcopenia, and utilizes AI-driven drug repurposing tools developed in partnership with SAS. As a private, pre-revenue company, it has established key collaborations with academic and research institutions like the NIHR Leicester BRC and Wellcome Leap to validate its therapeutic approach in age-related diseases.
View full company profile